Longshenrongfa Pharmaceutical Industry

300534
9.794.21% ( -0.43 )
Delay Midday Break: Nov 16, 11:30:00

Valuation

Current ValuationThe current P/E ratio is 126.16, above the reasonable range, cheaper than 1.54% of the time in the past 3 years, and the industry ranks 147/222, the industry Median 22.14.

126.16xP/E
Stock price¥10.22Earnings per share¥0.08

Historical Valuation

P/E ratioTypical rangeMedian

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
Industry median 22.14x
0326496128

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
Industry median 22.14x
0x40x80x120x160x200x
P/E ratio
Name/Symbol
688166SHBrightGene
123.14x--¥12.59B
688321SHChipscreen
125.56x--¥8.96B
300194SZFuan Pharmaceutical
120.87x--¥4.20B
603520SHStarry
127.82x1,350.00%¥3.40B
300534SZLongshenrongfa Pharmaceutical Industry
126.16x--¥3.10B

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.